Table 1.
Overview of nine lymphedema patients participating in this pilot study.
| ID | Diagnosis | Stage | Sex | Age(years) | Volumereduction (mL) | Height(cm) | Weight (kg) | BMI | Abdominalgirth (cm) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Secondary benign leglymphedema left | II–III | f | 59 | 1174 | 156 | 66 (−1) | 27 (−1) | 86 |
| 2 | Primary leg lymphedemaboth sides | III | m | 59 | 554 r, 1083 l,total 1637 | 169 | 94.2 (−1) | 33 | 112 (+1) |
| 3 | Primary leg lymphedema left | II | f | 39 | 1718 | 169 | 65.8 (−2.6) | 23 (−1) | 83 |
| 4 | Primary leg lymphedemaboth sides | III | m | 63 | 3839 r, 4032 l,total 7871 | 162 | 140.4 (−8.4) | 54 (−3) | 138 (−3) |
| 5 | Primary leg lymphedemaboth sides | II | m | 25 | 706 r, 444 l,total 1150 | 168 | 60.4 (+1.2) | 21 | 78 (+1) |
| 6 | Secondary benign leglymphedemaboth sides | II | f | 67 | 483 r, 574 l,total 1057 | 158 | 58.6 (+1.6) | 23 | 85 (+1) |
| 7 | Primary leg lymphedemaboth sides | III | f | 61 | 5110 r, 4113 l,total 9223 | 170 | 104.8 (−9.2) | 26 (−3) | 116 (−11) |
| 8 | Chronic secondary leglymphedemaboth sides | II | f | 58 | 1075 r, 947 l,total 2022 | 171 | 70.4 (−1) | 24 | 87 (−4) |
| 9 | Chronic leg lymphedemaboth sides | II-III | f | 65 | 1937 r, 1331 l,total 3268 | 155 | 107.2 (−4.8) | 45 (−2) | 145 (−2) |
Diagnosis, lymphedema stage, sex, age (in years), height and BMI (body mass index) and was determined for each patient prior to the study. Leg volume (l = left, r = right), weight and abdominal girth was assessed before and after complete decongestive therapy. Absolute changes are displayed in the brackets.